eUvidence

European Union member state

Medical literature search aligned with France’s national guidelines

As a European Union member state, France aligns medicines regulation with the European Medicines Agency (EMA), while HAS — Haute Autorité de Santé — anchors national clinical guidance.

Reference bodies for France

Evidence a clinician in France can audit

Ask a clinical question in natural language. eUvidence retrieves the relevant peer-reviewed papers, extracts the passages that bear on the question, and returns a cited summary. The reference list stays visible alongside the answer, so every sentence can be traced to a specific paper — title, journal, year, and DOI — and opened in one click.

The corpus is restricted to peer-reviewed journals and European regulatory and HTA references. That keeps answers anchored to the same evidence base that national bodies such as HAS and the EMA draw on, rather than the open web.

Frequently asked questions

Does eUvidence cover France's national guidelines?
eUvidence searches peer-reviewed medical literature and weights the answer toward the references a clinician in France works from — the national guidance associated with HAS (Haute Autorité de Santé) and EU-level sources such as the EMA. Every claim in a summary cites the underlying paper so you can verify it.
Is eUvidence a medical device in France?
No. eUvidence is a literature search and synthesis tool. It is not a medical device under EU MDR, has not been certified in France or elsewhere, and does not provide diagnosis or treatment recommendations. Results are summaries of published research; clinical decisions remain the responsibility of the treating clinician.
What is HAS?
HAS is Haute Autorité de Santé — the body in France associated with national clinical guidance or health-technology assessment. eUvidence does not republish its documents; it surfaces the peer-reviewed evidence that underpins clinical questions and lets you audit each source.
Which sources does eUvidence search?
Peer-reviewed medical journals indexed via standard databases, plus European regulatory and HTA references (EMA, NICE, HAS, KCE and equivalents). No preprints, no conference abstracts surfaced as primary evidence, no pharmaceutical marketing content.

Coverage across Europe

eUvidence aligns with national guidance across the EU, the UK, Ukraine, and the EEA. Explore another country: